Strattera
NDC Package 0002-5801-62

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Strattera is atomoxetine is used to treat attention-deficit hyperactivity disorder (ADHD) as part of a total treatment plan, including psychological, social, and other treatments. Marketed by Eli Lilly And Company, this product is identified by NDC 0002-5801 and is authorized under FDA application NDA021411.

Identification & Billing

NDC Package Code
0002-5801-62
Package Description
1 KIT in 1 BLISTER PACK
Product Code
0002-5801
11-Digit Billing Format
00002580162

Clinical Specifications

Proprietary Name
Strattera
Dosage Form
-
Usage Information
Atomoxetine is used to treat attention-deficit hyperactivity disorder (ADHD) as part of a total treatment plan, including psychological, social, and other treatments. It may help to increase the ability to pay attention, concentrate, stay focused, and stop fidgeting. It is thought to work by restoring the balance of certain natural substances (neurotransmitters) in the brain.

Regulatory & Marketing

Labeler Name
Eli Lilly And Company
FDA Application #
NDA021411
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
08-31-2014
End Marketing Date
01-03-2019
Listing Expiration
01-03-2019
Exclude Flag
D
Sample Package
Yes

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 0002-5801-62 identifies a specific commercial package of 1 kit in 1 blister pack of Strattera, labeled by Eli Lilly And Company. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Eli Lilly And Company on August 31, 2014. The current certification is valid through January 03, 2019.

What are the primary indications for this medication?

Atomoxetine is used to treat attention-deficit hyperactivity disorder (ADHD) as part of a total treatment plan, including psychological, social, and other treatments. It may help to increase the ability to pay attention, concentrate, stay focused, and stop fidgeting. It is thought to work by restoring the balance of certain natural substances (neurotransmitters) in the brain.

How is this Eli Lilly And Company product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 00002580162. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (4-4-2)
0002-5801-62
11-Digit CMS (5-4-2)
00002-5801-62

Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.